ArticleInternational journal of molecular sciences2019

Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines.

Jan J Bandolik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.